AzTrials
AzTrials

DelinquencyNCT01341626

Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up

A study testing Treatment Foster Care (TFCO) and Group Care in people with Delinquency and Drug Use, run by Oregon Social Learning Center at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system. Read more about this study

Who is it for?
Ages 13 to 18 years, women only
Conditions the study is for
Delinquency, Drug Use
What is being tested?
Treatment Foster Care (TFCO) and Group Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
2 sitesUnited States
Study dates
Jan 1997to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • female
  • 13-17 years old
  • at least one criminal referral in the prior year
  • court-mandated placement in out-of-home care

Who cannot join

  • Currently pregnant

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Oregon Social Learning Center

    Eugene, Oregon, 97401

  • University of Oregon

    Eugene, Oregon, 97403

Other trials in United States

About this study

Official title: Juvenile Justice Girls: Pathways to Adjustment and System Use in Young Adulthood

This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system.

Read the detailed description

Females under age 18 years old are the fastest-growing segment of the juvenile justice population and are at risk for negative co-occurring outcomes including drug abuse, HIV/STI risk, criminal behavior, and educational failure. As they enter young adulthood, this constellation of behaviors puts them at heightened risk for early parenthood and subsequent involvement in the child welfare system (for their parenting behaviors) and the adult corrections system (for criminal behaviors). Such system involvement is costly, and its prevention would be of great significance to public health; however, very little is known about factors leading to females' success/failure in young adulthood and factors that might prevent involvement in these two public systems. This study aims to further our understanding of the pathways to and the prevention of HIV/STI risk, drug use, and child welfare and adult corrections involvement by following-up 166 women who participated in two randomized intervention trials aimed at reducing delinquency during adolescence. In the original studies, juvenile justice girls who had been referred for out-of-home placement due to chronic delinquency were randomly assigned to services as usual or to Treatment Foster Care Oregon (TFCO, formerly known as MTFC). Efficacy of the intervention with this sample has been shown at 12- and 24-month follow-ups on criminal referral rates, days spent in locked settings, deviant peer associations, educational engagement, and pregnancy prevention. The investigators propose to examine the developmental pathways for these juvenile justice girls into young adulthood (ages 21-28 years) using innovative data collection and data analytic techniques, with foci on the long-term effects of TFCO, the mediators of young adult adjustment and child welfare/corrections involvement, and the cost effectiveness and cost avoidance of TFCO on these outcomes. The overarching aim is to identify potential targets for subsequent intervention. One in-person assessment is proposed with each female and her current romantic partner (if she has one); in addition, telephone interviews will be conducted every 6 months for the duration of the study, and system data from child welfare and adult corrections will be collected.

Being tested
Treatment Foster Care (TFCO), Group Care
Keywords
delinquency, drug use, HIV risk behavior, economic costs

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment Foster Care (TFCO)Behavioural

    Also called Multidimensional Treatment Foster Care

    Youth placed individually in well-trained and supervised foster homes. Basic components: (a) daily telephone contact with TFCO parents; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation. Services typically last approximately 6 months.

  • Group CareBehavioural

    Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%). Services typically last approximately 6 months.

Study groups in NCT01341626
Study groupRoleWhat they receive
Treatment Foster Care Oregon (TFCO)ExperimentalYouth are placed individually in well-trained and supervised foster homes. Basic components include: (a) daily telephone contact with TFCO parents using the Parent Daily Report; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation.
Receives: Behavioral: Treatment Foster Care (TFCO)
Group CareActive comparatorGroup Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%).
Receives: Behavioral: Group Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Delinquency

    Measured as self-reported criminal activity and count of official arrests and criminal referrals

    Measured: Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)

  2. substance use

    Measured via self-reported use and diagnostic interview assessment

    Measured: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)

Secondary outcomes (3)
  1. HIV risk behavior

    Measured as self-reported engagement in sexual behaviors

    Measured: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)

  2. economic costs

    Measured by comparing the costs of intervention delivery relative to the two intervention programs relative to costs incurred through time in detention, jail, and prison; relative to costs incurred due to child welfare involvement; and relative to symptom counts on self-report inventories.

    Measured: young adulthood (age 18-28; average of 7-year follow-up)

  3. Depression

    Measured on the CESD depression inventory and the Brief Symptom Inventory, and via diagnostic interview

    Measured: Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2011 (estimated)
  2. Study startJan 1997
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
166 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01341626
Sponsor's protocol ID
R01DA024672
Other IDs
R01DA015208, R01MH054257-01, R03MH091611
Status last verified
Feb 2022
First submitted
6 Apr 2011
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Harold GT, Kerr DC, Van Ryzin M, DeGarmo DS, Rhoades KA, Leve LD. Depressive symptom trajectories among girls in the juvenile justice system: 24-month outcomes of an RCT of Multidimensional Treatment Foster Care. Prev Sci. 2013 Oct;14(5):437-46. doi: 10.1007/s11121-012-0317-y.

    PubMed 23417664
  • Van Ryzin MJ, Leve LD. Affiliation with delinquent peers as a mediator of the effects of multidimensional treatment foster care for delinquent girls. J Consult Clin Psychol. 2012 Aug;80(4):588-96. doi: 10.1037/a0027336. Epub 2012 Feb 20.

    PubMed 22352857
  • Kerr DC, Leve LD, Chamberlain P. Pregnancy rates among juvenile justice girls in two randomized controlled trials of multidimensional treatment foster care. J Consult Clin Psychol. 2009 Jun;77(3):588-93. doi: 10.1037/a0015289.

    PubMed 19485598
  • Chamberlain P, Leve LD, Degarmo DS. Multidimensional treatment foster care for girls in the juvenile justice system: 2-year follow-up of a randomized clinical trial. J Consult Clin Psychol. 2007 Feb;75(1):187-93. doi: 10.1037/0022-006X.75.1.187.

    PubMed 17295579
  • Leve LD, Chamberlain P, Reid JB. Intervention outcomes for girls referred from juvenile justice: effects on delinquency. J Consult Clin Psychol. 2005 Dec;73(6):1181-5. doi: 10.1037/0022-006X.73.6.1181.

    PubMed 16392991
  • Level LD, Chamberlain P. Association with delinquent peers: intervention effects for youth in the juvenile justice system. J Abnorm Child Psychol. 2005 Jun;33(3):339-47. doi: 10.1007/s10802-005-3571-7.

    PubMed 15957561
  • Leve LD, Chamberlain P. A Randomized Evaluation of Multidimensional Treatment Foster Care: Effects on School Attendance and Homework Completion in Juvenile Justice Girls. Res Soc Work Pract. 2007 Nov 1;17(6):657-663. doi: 10.1177/1049731506293971.

    PubMed 18159224
  • Rhoades KA, Chamberlain P, Roberts R, Leve LD. MTFC for High Risk Adolescent Girls: A Comparison of Outcomes in England and the United States. J Child Adolesc Subst Abuse. 2013 Nov 1;22(5):435-449. doi: 10.1080/1067828X.2013.788887.

    PubMed 24003300
  • Leve LD, Kerr DC, Harold GT. Young Adult Outcomes Associated with Teen Pregnancy Among High-Risk Girls in an RCT of Multidimensional Treatment Foster Care. J Child Adolesc Subst Abuse. 2013 Sep 1;22(5):421-434. doi: 10.1080/1067828X.2013.788886.

    PubMed 24453470
  • Poulton R, Van Ryzin MJ, Harold GT, Chamberlain P, Fowler D, Cannon M, Arseneault L, Leve LD. Effects of multidimensional treatment foster care on psychotic symptoms in girls. J Am Acad Child Adolesc Psychiatry. 2014 Dec;53(12):1279-87. doi: 10.1016/j.jaac.2014.08.014. Epub 2014 Sep 16.

    PubMed 25457926
  • Kerr DC, DeGarmo DS, Leve LD, Chamberlain P. Juvenile justice girls' depressive symptoms and suicidal ideation 9 years after Multidimensional Treatment Foster Care. J Consult Clin Psychol. 2014 Aug;82(4):684-93. doi: 10.1037/a0036521. Epub 2014 Apr 14.

    PubMed 24731234
  • Rhoades KA, Leve LD, Harold GT, Kim H, Chamberlain P. Drug Use Trajectories After a Randomized Controlled Trial of MTFC: Associations with Partner Drug Use. J Res Adolesc. 2014 Mar 1;24(1):40-54. doi: 10.1111/jora.12077.

    PubMed 24729667

Questions about this trial

What is this clinical trial studying?

A study testing Treatment Foster Care (TFCO) and Group Care in people with Delinquency and Drug Use, run by Oregon Social Learning Center at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Delinquency (time frame: Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01341626, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in